ABSTRACT
Hilar cholangiocarcinoma (HCCA) is a common malignant tumor of the extrahepatic bile duct and has the features of special anatomical location, tumor growth along the bile duct, high degree of malignancy, and easy involvement of liver parenchyma. At present, the treatment methods for HCCA include surgical resection, non-surgical biliary drainage, neoadjuvant chemoradiotherapy, and photodynamic therapy, but surgical resection is still the preferred method. There are still controversies over the need for preoperative biliary drainage, portal vein thrombosis, and extent of surgical resection. This article elaborates on the research advances in the clinical typing of HCCA, preoperative examination and diagnosis, and treatment methods.
ABSTRACT
0.05)Conclusion There are some free cancer cells in the prepheral blood of some patients with gastric cancer before operation. Pulling and stimulating tumor in the operation may increase cancer cell dissemination.Simple ligation of peripheral veins around stomach could not completely prevent cancer cell dissemination in the peripheral blood.
ABSTRACT
Hilar cholangiocarcinoma (HCCA) is a common malignant tumor of the extrahepatic bile duct and has the features of special anatomical location, tumor growth along the bile duct, high degree of malignancy, and easy involvement of liver parenchyma. At present, the treatment methods for HCCA include surgical resection, non-surgical biliary drainage, neoadjuvant chemoradiotherapy, and photodynamic therapy, but surgical resection is still the preferred method. There are still controversies over the need for preoperative biliary drainage, portal vein thrombosis, and extent of surgical resection. This article elaborates on the research advances in the clinical typing of HCCA, preoperative examination and diagnosis, and treatment methods.